Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
How effective is the flu shot this year? New report shows promising results - 2Steinmeier honours Italian 'guest workers' who rebuilt German economy
- 35 Critical Rules For Business Regulation Chiefs
- 4'People We Meet on Vacation' is the 1st of many Emily Henry adaptations: What other books turned movies to look forward to
- 52024 Style: The It-Things You Want in Your Closet
- The Magnificence of Extraordinariness: Presenting Valuable Adornments and Gemstones
- 6 Popular Men's Aromas On the planet
- Foods with healthy-sounding buzzwords could be hiding added sugar in plain sight
- Minneapolis ICE shooting live updates: Protests continue over agent's killing of Renee Nicole Good; Walz puts National Guard on standby
- Understanding climate change in America: Skepticism, dogmatism and personal experience
- American tourists left stranded in the Caribbean following flight cancellations after airspace closed for Maduro operation
- The 10 Most Persuasive Forerunners in Innovation
- EU Council president: Ukraine should receive binding guarantees
- Figuring out Significant Regulations and Guidelines for Organizations
